Pharmacogenetics of membrane transporters: a review of current approaches.
This chapter provides a review of the pharmacogenetics of membrane transporters, including adenosine triphosphate-binding cassette (ABC) transporters and organic anion transporting proteins (OATPs). Membrane transporters are heavily involved in drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have a significant effect on the absorption, distribution, metabolism, and excretion of compounds. The techniques used to identify substrates and inhibitors of these proteins and subsequently assess the effect of genetic mutation on transport, both in vitro and in vivo, are outlined and discussed. Finally, studies linking transporter genotype with clinical outcomes are discussed.
Sissung
Tristan M
TM
Clinical Pharmacology Program, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Gardner
Erin R
ER
Gao
Rui
R
Figg
William D
WD
D018528:ATP-Binding Cassette Transporters / Q000235:genetics / Q000378:metabolism*; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D027361:Organic Anion Transporters / Q000235:genetics / Q000378:metabolism*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010597:Pharmacogenetics; D010599:Pharmacokinetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D016896:Treatment Outcome
D018528:ATP-Binding Cassette Transporters; D027361:Organic Anion Transporters; D004364:Pharmaceutical Preparations